In the high-risk world of biotech investing, there are no guarantees of success. Still, sometimes investors can find places where the odds look reasonable enough to consider buying shares.
News & Analysis: IQVIA Holdings, Inc.
Everything is going well for the life sciences service provider.
IQV earnings call for the period ending June 30, 2019.
The life science service provider's numbers continue to trend in the right direction.
IQV earnings call for the period ending March 31, 2019.
Demand for the company's research and development solutions are as strong as ever.
IQV earnings call for the period ending December 31, 2018.
Find out how CROs profit from the biotech boom no matter what happens in the clinic.
Revenue and earnings continued to march higher, but this key indicator of future demand should have bulls smiling from ear to ear.
IQV earnings call for the period ending September 30, 2018.